Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ARMD1 | Q6PIY5 | Armadillo-like helical domain containing protein 1 (p40) | Predicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| ARMD4 | Q86TY3 | Armadillo-like helical domain-containing protein 4 (Upstream of mTORC2 protein) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.38 | |||
| ARP10 | Q9NZ32 | Actin-related protein 10 (Actin-related protein 11) (hARP11) | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.38 | |||||
| ARVC | O00192 | Splicing regulator ARVCF (Armadillo repeat protein deleted in velo-cardio-facial syndrome) | Predicted intracellular proteins | Fusion and delivery mediation | 1 | 0.38 | ||||
| ATG3 | Q9NT62 | Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like) (hApg3) (Protein PC3-96) | Predicted intracellular proteinsTransporters | Fusion and delivery mediationImmune mediation | 1 | 0.38 | ||||
| ATS1 | Q9UHI8 | A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAM-TS 1) (ADAM-TS1) (ADAMTS-1) (EC 3.4.24.-) (METH-1) | Cancer-related genesPlasma proteinsPredicted intracellular proteinsPredicted secreted proteinsTransporters | Clinical-translation mediationMetabolism mediation | 1 | 0.38 | ||||
| ATS2 | O95450 | A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI) | Disease related genesEnzymesHuman disease related genesPlasma proteinsPotential drug targetsPredicted secreted proteins | Clinical-translation mediationMetabolism mediation | 1 | 0.38 | ||||
| ATX10 | Q9UBB4 | Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein) | Disease related genesEssential proteinsHuman disease related genesPredicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| AXIN2 | Q9Y2T1 | Axin-2 (Axin-like protein) (Axil) (Axis inhibition protein 2) (Conductin) | Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins | Metabolism mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| B2MG | P61769 | Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3] | Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted secreted proteinsTransporters | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.38 | ||||
| BCAP | Q6ZUJ8 | Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1) | Predicted intracellular proteins | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| BCAR1 | P56945 | Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas) | Plasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| BCAR3 | O75815 | Breast cancer anti-estrogen resistance protein 3 (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) | Predicted intracellular proteins | Adhesion and uptake mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| BCR | P11274 | Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26) | Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| BEND6 | Q5SZJ8 | BEN domain-containing protein 6 | Predicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| BI2L1 | Q9UHR4 | BAR/IMD domain-containing adapter protein 2-like 1 (Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1) (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate) | Predicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| BIN2 | Q9UBW5 | Bridging integrator 2 (Breast cancer-associated protein 1) | Plasma proteinsPredicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.38 | ||||
| BMX | P51813 | Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) | EnzymesPredicted intracellular proteins | Immune mediationMetabolism mediation | 1 | 0.38 | ||||
| BRAF | P15056 | Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1) | Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsTransporters | MelanomaSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.38 | |||
| BTBDI | B2RXH4 | BTB/POZ domain-containing protein 18 | Predicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| CA054 | Q8WWF1 | Uncharacterized protein C1orf54 | Predicted secreted proteins | Other mediation | 1 | 0.38 | ||||
| CA074 | Q96LT6 | UPF0739 protein C1orf74 | Predicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| CA2D2 | Q9NY47 | Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2] | Disease related genesFDA approved drug targetsPredicted intracellular proteinsTransporters | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.38 | |||
| CABP8 | Q9BXU9 | Calcium-binding protein 8 (CaBP8) (Calneuron I) (Calneuron-1) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediation | 1 | 0.38 | |||
| CAH9 | Q16790 | Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1) | EnzymesFDA approved drug targetsMetabolic proteinsPredicted membrane proteinsTransporters | 1 | Clinical-translation mediationMetabolism mediation | 1 | 0.38 |